PARIS: The Paris appeals court ruled on Wednesday that an international arrest warrant for Syrian President Bashar Assad issued by France for alleged complicity in war crimes during Syria’s civil war is valid and remains in place.
Jeanne Sulzer and Clemence Witt, lawyers who represented the plaintiffs, and non-governmental organizations behind the complaint hailed the decision as a historic judgment.
In May, French anti-terrorism prosecutors asked the Paris appeals court to rule on lifting the arrest warrant for Assad, saying he has absolute immunity as a serving head of state.
“It’s the first time that a national court has recognized that the personal immunity of a serving head of state is not absolute,” the lawyers said in a statement.
French judicial authorities issued international arrest warrants last November for Assad; his brother Maher Assad, the commander of the 4th Armored Division; and two Syrian generals, Ghassan Abbas and Bassam Al-Hassan, for alleged complicity in war crimes and crimes against humanity. They include a 2013 chemical attack on then opposition-held Damascus suburbs.
Victims of the attack welcomed France’s decision to issue arrest warrants as a reminder of the horrors of Syria’s civil war.
The prosecutors did not challenge the warrants for Assad’s brother and the two generals during a closed hearing on the issue on May 15.
International arrest warrants for a serving head of state are very rare and the decision by the Paris court to issue one for the Syrian president represented a strong criticism of Assad’s leadership at a time when some countries were welcoming him back into the diplomatic fold.
More than 1,000 people were killed and thousands were injured in the August 2013 attacks on Douma and Eastern Ghouta.
The investigation into the attacks has been conducted under universal jurisdiction in France by a special unit of the Paris Judicial Court. It was opened in 2021 in response to a criminal complaint by the survivors, and filed by the Syrian Center for Media and Freedom of Expression.
Assad’s government was widely deemed by the international community to be responsible for the sarin gas attack in the then-opposition-held Damascus suburb of eastern Ghouta. The Syrian government and its allies have denied responsibility and said the attack was carried out by opposition forces trying to push for foreign military intervention.
The United States threatened military retaliation in the aftermath of the attack, with then-President Barack Obama saying use of chemical weapons by Assad would be Washington’s “red line.” However, the US public and Congress were wary of a new war, as invasions in Afghanistan and Iraq had turned into quagmires.
Washington settled for a deal with Moscow for Syria to give up its chemical weapons stockpile.
Syria says it eliminated its chemical arsenal under the 2013 agreement. However, watchdog groups have continued to allege chemical attacks by Syrian government forces since then.
Syria is not a member of the International Criminal Court, meaning the court does not have jurisdiction there. However, human rights lawyers in the past have urged prosecutors to open an investigation into crimes during the country’s civil war, arguing that the court could exercise jurisdiction over Syrian civilians forced into Jordan, which is a member of the court.
So far, the court has not opened an investigation.
In a separate case, a Paris court last month sentenced three high-ranking Syrian officials in absentia to life in prison for complicity in war crimes in a landmark case against Assad’s government and the first such case in Europe.
Paris court upholds validity of France’s arrest warrant for Syrian President Bashar Assad
https://arab.news/8sr4u
Paris court upholds validity of France’s arrest warrant for Syrian President Bashar Assad
- Jeanne Sulzer and Clemence Witt, lawyers who represented the plaintiffs, and NGOs behind the complaint hailed the decision as a historic judgment
- “It’s the first time that a national court has recognized that the personal immunity of a serving head of state is not absolute,” the lawyers said
UPDATE 1-Trump expected to address potential easing of marijuana regulations on Thursday
- Trump considers executive order to reclassify marijuana
WASHINGTON: President Donald Trump is expected to address the potential loosening of federal regulations on marijuana on Thursday, according to a White House official, setting up a decision that could sharply reverse decades of US drug policy. Trump said on Monday that he was considering an executive order to reclassify marijuana as a less dangerous drug — a decision that could reshape the cannabis industry, ease criminal penalties and unlock billions in research funding. Such a shift would represent one of the most significant federal changes to marijuana policy in decades, reducing oversight to the level of common prescription drugs and potentially opening doors long closed to banks and investors.
The precise contents of Trump’s potential order were not immediately clear. While Trump “is currently expected to address marijuana rescheduling tomorrow, any details of this potential action until officially announced by the White House are speculation,” said the Trump administration official, who declined to be named. Under the US Controlled Substances Act, marijuana is listed as a Schedule I substance like heroin, ecstasy and peyote. That classification indicates it has a high potential for abuse and no currently accepted medical use. Local authorities often impose more lax regulations over weed, allowing medical or recreational use. Trump told reporters in the Oval Office on Monday that he was looking at pushing for weed to be reclassified under Schedule III, alongside Tylenol mixed with codeine, ketamine and testosterone. “We are looking at that very strongly,” he said at the time.
Initial reports that Trump might loosen restrictions on the psychoactive drug sent stocks of cannabis-related companies higher. They stand to benefit by making more cannabis products. “Rescheduling it would really open the floodgates to more and more smart conversation about the proper way to regulate and tax cannabis, would show that the federal government is real about getting to coming up with a solution so that these businesses can operate like every other business,” said Steve Levine, partner and co-leader of the law firm Husch Blackwell’s national cannabis practice. Funding remains one of the biggest challenges for cannabis producers, as federal restrictions keep most banks and institutional investors out of the sector, forcing pot producers to turn to costly loans or alternative lenders. The Biden administration previously asked the Department of Health and Human Services to review marijuana’s classification, and the agency recommended moving it to Schedule III classification. The Drug Enforcement Administration has to review the recommendation and will decide on the reclassification. “A potential reclassification in the US would be an important step toward normalizing cannabis policy, improving research, supporting patient care, and expanding access to regulated and safe channels for both consumers and patients,” said a spokesperson for Canopy Growth, a Canada-based cannabis firm.










